Continuous purification of therapeutics - removing critical barriers in manufacturing by MCSGP 

The challenges in the purification of oligonucleotides (incl. RNA / DNA) and peptides of time, cost, yield and purity can be overcome with a technique called MCSGP. Multi-column chromatography plays a key role in the future success for cost effective production of these emerging therapies. This webinar illustrates how MCSGP works and then provides Case Studies of the technology on RNA and DNA feed stocks.